A new approach of primary angioplasty for ST-elevation acute myocardial infarction based on minimalist immediate mechanical intervention

Coronary Artery Disease

Volumn 17, Issue 3, 2006, Pages 261-269

  Isaaz, Karl ^a,b   Robin, Christophe ^a   Cerisier, Alexis ^a   Lamaud, Michel ^a   Richard, Laure ^a   Da Costa, Antoine ^a   Sabry, Mohamed Hassan ^a   Gerenton, Claude ^a   Blanc, Jean Louis ^a  

^a UNIVERSITÉ JEAN MONNET   (France)

^b HÔPITAL NORD   (France)

Author keywords

Acute myocardial infarction; No reflow; Percutaneous direct intervention; Stent

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; CLOPIDOGREL; HEPARIN;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTERY DISSECTION; ARTICLE; ARTIFICIAL EMBOLISM; BALLOON CATHETER; BYPASS SURGERY; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY OBSTRUCTION; CORONARY STENT; DISEASE SEVERITY; FEMALE; HEART INFARCTION; HUMAN; INTERVENTIONAL CARDIOVASCULAR PROCEDURE; MAJOR CLINICAL STUDY; MALE; MINIMALIST IMMEDIATE MECHANICAL INTERVENTION; PRIORITY JOURNAL; RECANALIZATION; REPERFUSION; ST SEGMENT ELEVATION; TRANSLUMINAL CORONARY ANGIOPLASTY; VASCULAR DISEASE;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; BLOOD VESSEL PROSTHESIS IMPLANTATION; CORONARY ANGIOGRAPHY; CORONARY CIRCULATION; CORONARY STENOSIS; CORONARY THROMBOSIS; ELECTROCARDIOGRAPHY; FEMALE; FIBRINOLYTIC AGENTS; HEART CATHETERIZATION; HEART CONDUCTION SYSTEM; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; PROSPECTIVE STUDIES; RESEARCH DESIGN; STENTS; TREATMENT OUTCOME;

EID: 33748333084     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019501-200605000-00010     Document Type: Article

References (35)

1. Grines C, Patel A, Zijlstra F, Weaver WD, Granger C, Simes RJ, PCAT Collaborators. Percutaneous transluminal coronary angioplasty. Primary coronary angioplasty compared with intravenous thrombolytic therapy for acute myocardial infarction: six-month follow up and analysis of individual patient data from randomized trials. Am Heart J 2003; 145:47-57.
2. Suryapranata H, van't Hof AW, Hoorntje JC, de Boer MJ, Zijlstra F. Randomized comparison of coronary stenting with balloon angioplasty in selected patients with acute myocardial infarction. Circulation 1998; 97:2502-2505.
3. Rodriguez A, Bernardi V, Fernandez M, Mauvecin C, Ayala F, Santaera O, et al. In-hospital and late results of coronary stents versus conventional balloon angioplasty in acute myocardial infarction (GRAMI Trial). Gianturco-GiaRoubin in Acute Myocardial Infarction. Am J Cardiol 1998; 81:1286-1291.
4. Antoniucci D, Santoro GM, Bolognese L, Valenti R, Trapani M, Fazzini PF. A clinical trial comparing primary stenting of the infarct-related artery with optimal primary angioplasty for acute myocardial infarction: Results from the Florence Randomized Elective Stenting in Acute Coronary Occlusions (FRESCO) Trial. J Am Coll Cardiol 1998; 31:1234-1239.
5. Saito S, Hosokawa G, Tanaka S, Nakamura S. Primary stent implantation is superior to balloon angioplasty in acute myocardial infarction: Final results of the Primary Angioplasty Versus Stent Implantation in Acute Myocardial Infarction (PASTA) Trial. PASTA Trial Investigators. Catheter Cardiovasc Interv 1999; 48:262-268.
6. Grines CL, Cox DA, Stone GW, Garcia E, Mattos LA, Giambartolomei A, et al. Coronary angioplasty with or without stent implantation for acute myocardial infarction. Stent Primary Angioplasty in Myocardial Infarction Study Group. N Engl J Med 1999; 341:1949-1956.
7. Fry JA, Grines CL. Does primary stenting in acute myocardial infarction increase mortality? ACC Curr J Rev 2001; 10:68-71.
8. Maillard L, Hamon M, Khalife K, Steg PG, Beygui F, Guermonprez JL, et al. Comparison of systematic stenting and conventional balloon angioplasty during primary percutaneous transluminal coronary angioplasty for acute myocardial infarction. STENTIM-STENTI2 Investigators. J Am Coll Cardiol 2000; 35:1729-1736.
9. Erbel R, Heusch G. Coronary microembolization: its role in acute coronary syndromes and interventions. Herz 1999; 24:558-575.
10. Topol EJ, Yadav JS. Recognition of the importance of embolization in atherosclerotic vascular disease. Circulation 2000; 101:570-580.
11. Escobar J, Guarda E, Marchant E, Fajuri A, Martinez A, Pichard A. Relation of stenting to decreased coronary blood flow during primary angioplasty in acute myocardial infarction. Am J Cardiol 2001; 88:1410-1412, A6.
12. Henriques JP, Zijlstra F, Ottervanger JP, de Boer MJ, van't Hof AW, Hoorntje JC, et al. Incidence and clinical significance of distal embolization during primary angioplasty for acute myocardial infarction. Eur Heart J 2002; 23:1112-1117.
13. Yusuf S, Zhao F, Mehta SR, Chrolavicius S, Tognoni G, Fox KK, Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 2001; 345:494-502.
14. Mehta SR, Yusuf S, Peters RJ, Bertrand ME, Lewis BS, Natarajan MK, et al., Clopidogrel in Unstable Angina to Prevent Recurrent Events trial (CURE) Investigators. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: The PCI-CURE Study. Lancet 2001; 358:527-533.
15. Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. The EPIC Investigation. N Engl J Med 1994; 330:956-961.
16. Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina: The CAPTURE Study. Lancet 1997; 349:1429-1435.
17. The EPILOG Investigators. Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization. N Engl J Med 1997; 336:1689-1696.
18. Randomised placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade. The EPISTENT Investigators. Evaluation of platelet IIb/IIIa inhibitor for stenting. Lancet 1998; 352:87-92.
19. Brener SJ, Barr LA, Burchenal JE, Katz S, George BS, Jones AA, et al. Randomized, placebo-controlled trial of platelet glycoprotein IIb/IIIa blockade with primary angioplasty for acute myocardial infarction. ReoPro and Primary PTCA Organization and Randomized Trial (RAPPORT) Investigators. Circulation 1998; 98:734-741.
20. Gibson CM, de lemos JA, Murphy SA, Marble SJ, McCabe CH, Cannon CP, et al., for the TIMI Study Group. Combination therapy with abciximab reduces angiographically evident thrombus in acute myocardial infarction. A TIMI 14 substudy. Circulation 2001; 103:2550-2554.
21. Gibson CM, Cannon CP, Daley WL, Dodge JT, Alexander B, Marble SJ, et al. The TIMI frame count: a quantitative method of assessing coronary artery flow. Circulation 1996; 93:870-888.
22. Johanson P, Jernberg T, Gunnarsson G, Lindahl B, Wallentin L, Dellborg M. Prognostic value of ST-segment resolution-when and what to measure. Eur Heart J 2003; 24:337-345.
23. Cannon CP, Gibson CM, McCabe CH, Adgey AA, Schweiger MJ, Sequeira RF, et al. TNK-tissue plasminogen activator compared with front-loaded alteplase in acute myocardial infarction: Results of the TIMI 10B Trial. Thrombolysis in Myocardial Infarction (TIMI) 10B Investigators. Circulation 1998; 98:2805-2814
24. Antman EM, Giugliano RP, Gibson CM, McCabe CH, Coussement P, Kleiman NS, et al. Abciximab facilitates the rate and extent of thrombolysis: results of the thrombolysis in myocardial infarction (TIMI) 14 trial. The TIMI 14 Investigators. Circulation 1999; 99:2720-2732.
25. Giugliano RP, Roe MT, Harrington RA, Gibson CM, Zeymer U, Van de Werf F, et al. INTEGRITI Investigators. Combination reperfusion therapy with eptifibatide and reduced-dose tenecteplase for ST-elevation myocardial infarction: Results of the Integrilin and Tenecteplase in Acute Myocardial Infarction (INTEGRITI) Phase II Angiographic Trial. J Am Coll Cardiol 2003; 41:1251-1260.
26. Kastrati A, Pache J, Dirschinger J, Neumann FJ, Walter H, Schmitt C, et al. Primary intracoronary stenting in acute myocardial infarction: long-term clinical and angiographic follow-up and risk factor analysis. Am Heart J 2000; 139:208-216.
27. Le May MR, Labinaz M, Beanlands RS, Laramee LA, O'Brien ER, Marquis J-F, et al. Usefulness of intracoronary stenting in acute myocardial infarction. Am J Cardiol 1996; 78:148-152.
28. Mehta RH, Harjai KJ, Cox D, Stone GW, Brodie B, Boura J, et al. Clinical and angiographic correlates and outcomes of suboptimal coronary flow in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention. J Am Coll Cardiol 2003; 42:1739-1746
29. Stone GW, Grines CL, Cox DA, Garcia E, Tcheng JE, Griffin JJ, et al., for the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) Investigators. Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction. N Engl J Med 2002; 346:957-966.
30. Montalescot G, Barragan P, Wittenberg O, Ecollan P, Elhadad S, Vilain P, et al. for the ADMIRAL investigators. Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction. N Engl J Med 2001; 344:1895-1903.
31. Maes A, Van de Werf F, Nuyts J, Bormans G, Desmet W, Mortelmans L. Impaired myocardial tissue perfusion early after successful thrombolysis. Impact on myocardial flow, metabolism, and function at late follow-up. Circulation 1995; 92:2072-2078.
32. Hamada S, Nishiue T, Nakamura S, Sugiura T, Kamihata H, Miyoshi H, et al. TIMI frame count immediately after primary coronary angioplasty as a predictor of functional recovery in patietns with TIMI 3 reperfused acute myocardiol infarction. J Am Coll Cardiol 2000; 38:666-671.
33. Feldman LJ, Coste P, Furber A, Dupouy P, Slama MS, Monassier JP, et al., Steg PG for the French Optimal Stenting (FROST)-2 Investigators. Incomplete resolution of ST-segment elevation is a marker of transient microcirculatory dysfunction after stenting fir acute myocardial infarction. Circulation 2003; 107:2684-2689.
34. Piana RN, Paik GY, Moscucci M, Cohen DJ, Gibson CM, Kugelmass AD, et al. Incidence and treatment of no-reflow after percutaneous coronary intervention. Circulation 1994; 89:2514-2518.
35. Kaul U, Sapra R, Singh B, Sudan D, Ghose T, Dixit NS, et al. Reversal of slow flow phenomenon during primary stenting by bail-out administration of abciximab. Int J Cardiovasc Interv 2000; 3:35-39.